BioCentury
ARTICLE | Company News

Management tracks

October 14, 2016 7:00 AM UTC

Gene therapy company Adverum Biotechnologies Inc. (NASDAQ:ADVM) named Amber Salzman CEO, replacing Paul Cleveland. Salzman was president and COO, and will remain president. Cleveland will be the company's executive chairman.

Cell therapy company Kite Pharma Inc. (NASDAQ:KITE) named Chris Nowers head of Europe. He was head of hematology and immuno-oncology in France at Bristol-Myers Squibb Co. (NYSE:BMY). ...